文献速递乳腺癌

老年乳腺癌患者的监测性乳腺X线摄影——我们能否停止?:一篇综述

Surveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A Review.
PubMed 文献 · JAMA Oncol · 2017-01-01

约4%至5%的乳腺癌幸存者在诊断后5年内会发生新的同侧或对侧乳腺癌事件,指南推荐对残留乳腺组织者每年行监测性乳腺X线摄影。老年患者缺乏前瞻性数据,证据多来自观察性、回顾性研究。作者建议对70岁及以上幸存者个体化决策:局部治疗完成后6至12个月行1次影像,健康女性随后每年或每两年监测,预期寿命不足5至10年者无论年龄均停止乳腺X线摄影。

要点

  • 约4%至5%的乳腺癌幸存者在诊断后5年内发生同侧或对侧乳腺事件。
  • 老年幸存者监测证据多来自观察性、回顾性数据,缺乏前瞻性数据。
  • 作者建议70岁及以上者局部治疗后6至12个月行1次影像,健康者随后每年或每两年监测。

核心结论

  • 作者建议重新构建老年乳腺癌幸存者监测性乳腺X线摄影的讨论,考虑停止监测,并纳入预期寿命、后续乳腺事件估计风险和患者偏好。

研究设计与样本

  • 综述,检索范围未在原文中明确报告。

主要发现

  • 约4%至5%的乳腺癌幸存者在诊断后5年内发生新的同侧或对侧乳腺癌事件。
  • 乳腺癌诊断时年龄增长和激素治疗与乳腺事件风险降低相关。
  • 多数老年乳腺癌幸存者最终死于非乳腺癌相关原因。

关键数值与推荐

  • 作者推荐对老年乳腺癌幸存者的监测性乳腺影像进行个体化决策。
  • 作者建议对70岁及以上女性:局部治疗完成后6至12个月行1次影像,健康女性随后每年或每两年行监测性乳腺X线摄影。
  • 作者建议预期寿命不足5至10年的患者停止乳腺X线摄影,无论年龄。
  • 决策还应纳入是否正在接受激素治疗、预期寿命是否异常以及个体乳腺事件风险是否高于或低于乳腺癌幸存者平均风险。

临床怎么用

  • 作者建议对70岁及以上乳腺癌幸存者采用个体化监测策略:局部治疗后6至12个月行1次影像,健康者随后每年或每两年监测。
  • 作者建议预期寿命不足5至10年者无论年龄停止乳腺X线摄影。
  • 作者建议决策时纳入激素治疗、预期寿命、个体乳腺事件风险和患者偏好。

局限性

  • 老年患者监测策略的具体指南有限。
  • 该人群监测性乳腺X线摄影获益与危害的前瞻性数据缺乏。
  • 多数证据来自观察性、回顾性数据,常来自一般人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Approximately 4% to 5% of breast cancer survivors will develop a new ipsilateral or contralateral cancer (in-breast event) over the 5 years following diagnosis, and annual surveillance mammography is recommended for those with residual breast tissue. The risk for such in-breast events persists over time, though increasing age at cancer diagnosis and treatment with hormonal therapy are associated with lower risk, and most older survivors of breast cancer will ultimately die from nonbreast cancer-related causes. Specific guidelines for surveillance strategies in older patients are limited. Prospective data on the benefits and harms of surveillance mammography in this population are lacking, and most of the evidence is derived from observational, retrospective data, often in the general population. OBSERVATIONS: We review the current recommendations for breast cancer screening and surveillance for older patients, the current evidence for ipsilateral and contralateral breast cancer risks in older survivors of breast cancer, and suggested approaches for discussions about surveillance mammography with older patients. We recommend individualized decision making for surveillance breast imaging in older survivors of breast cancer, with consideration of the following strategy for women 70 years or older: 1-time imaging 6 to 12 months after completion of local therapy followed by annual or biennial surveillance mammography for healthy women and cessation of mammography in patients whose life expectancy is less than 5 years to 10 years, regardless of age. Decisions on mammographic surveillance should also incorporate whether hormonal therapy is being administered, whether a patient's anticipated life expectancy is extraordinary, and whether a patient's individual risk for in-breast events is higher (or lower) than average risk for breast cancer survivors. CONCLUSIONS AND RELEVANCE: We propose reframing discussions around surveillance mammography in older breast cancer survivors and to consider cessation while taking into account life expectancy, the estimated risk for subsequent in-breast events, and patient preferences.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Freedman RA, Keating NL, Partridge AH, et al. Surveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A Review. JAMA Oncol. 2017. PMID: 27892991. doi:10.1001/jamaoncol.2016.3931

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。